Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma

Few studies have analyzed the details of neoadjuvant chemotherapy (NAC)-induced changes in patients with upper tract urothelial carcinoma. This study aimed to describe the impact of down-grading ipsilateral hydronephrosis by NAC for ureteral carcinoma. An observational study was conducted in 32 pati...

Full description

Bibliographic Details
Main Authors: Makito Miyake, Nagaaki Marugami, Yuya Fujiwara, Kazumasa Komura, Teruo Inamoto, Haruhito Azuma, Hiroaki Matsumoto, Hideyasu Matsuyama, Kiyohide Fujimoto
Format: Article
Language:English
Published: MDPI AG 2019-12-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/10/1/10
id doaj-3c15a93a78da40ccb0ed6a7493086145
record_format Article
spelling doaj-3c15a93a78da40ccb0ed6a74930861452020-11-25T02:06:56ZengMDPI AGDiagnostics2075-44182019-12-011011010.3390/diagnostics10010010diagnostics10010010Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral CarcinomaMakito Miyake0Nagaaki Marugami1Yuya Fujiwara2Kazumasa Komura3Teruo Inamoto4Haruhito Azuma5Hiroaki Matsumoto6Hideyasu Matsuyama7Kiyohide Fujimoto8Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, JapanDepartment of Radiology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, JapanDepartment of Urology, Osaka Medical College, 2-7 Daigakumachi, Takatsuki, Osaka 569-8686, JapanDepartment of Urology, Osaka Medical College, 2-7 Daigakumachi, Takatsuki, Osaka 569-8686, JapanDepartment of Urology, Osaka Medical College, 2-7 Daigakumachi, Takatsuki, Osaka 569-8686, JapanDepartment of Urology, Osaka Medical College, 2-7 Daigakumachi, Takatsuki, Osaka 569-8686, JapanDepartment of Urology, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube 755-8505, JapanDepartment of Urology, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube 755-8505, JapanDepartment of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, JapanFew studies have analyzed the details of neoadjuvant chemotherapy (NAC)-induced changes in patients with upper tract urothelial carcinoma. This study aimed to describe the impact of down-grading ipsilateral hydronephrosis by NAC for ureteral carcinoma. An observational study was conducted in 32 patients with cT1-3N0M0 ureteral carcinoma treated with NAC and radical nephroureterectomy. Hydronephrosis was classified into five grades based on computed tomography findings. We focused on the differences between the baseline and post-NAC status of ipsilateral hydronephrosis, radiographic tumor response, and blood markers. Down-grading, no change, and up-grading was observed in 10 (31%), 21 (66%), and 1 (3%) patients, respectively. In univariate analysis, locally advanced disease (cT3), severe hydronephrosis (grade 3/4) at baseline, no change/up-grading of hydronephrosis after NAC, and pathological lymphovascular involvement were identified as potential prognostic factors of progression-free and cancer-specific survival after radical nephroureterectomy. Locally advanced disease (cT3) at baseline and no change/up-grading of hydronephrosis by NAC were independently associated with poor progression-free survival. Notably, none of the patients with NAC-induced down-grading of hydronephrosis died of ureteral carcinoma during the follow-up. We reported the prognostic impact of down-grading of ipsilateral hydronephrosis, which could serve as a useful aid or clinical marker for decision-making.https://www.mdpi.com/2075-4418/10/1/10ureteral neoplasmshydronephrosisneoadjuvant therapyneoplasm recurrencesurvivaldisease progression
collection DOAJ
language English
format Article
sources DOAJ
author Makito Miyake
Nagaaki Marugami
Yuya Fujiwara
Kazumasa Komura
Teruo Inamoto
Haruhito Azuma
Hiroaki Matsumoto
Hideyasu Matsuyama
Kiyohide Fujimoto
spellingShingle Makito Miyake
Nagaaki Marugami
Yuya Fujiwara
Kazumasa Komura
Teruo Inamoto
Haruhito Azuma
Hiroaki Matsumoto
Hideyasu Matsuyama
Kiyohide Fujimoto
Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma
Diagnostics
ureteral neoplasms
hydronephrosis
neoadjuvant therapy
neoplasm recurrence
survival
disease progression
author_facet Makito Miyake
Nagaaki Marugami
Yuya Fujiwara
Kazumasa Komura
Teruo Inamoto
Haruhito Azuma
Hiroaki Matsumoto
Hideyasu Matsuyama
Kiyohide Fujimoto
author_sort Makito Miyake
title Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma
title_short Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma
title_full Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma
title_fullStr Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma
title_full_unstemmed Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma
title_sort down-grading of ipsilateral hydronephrosis by neoadjuvant chemotherapy correlates with favorable oncological outcomes in patients undergoing radical nephroureterectomy for ureteral carcinoma
publisher MDPI AG
series Diagnostics
issn 2075-4418
publishDate 2019-12-01
description Few studies have analyzed the details of neoadjuvant chemotherapy (NAC)-induced changes in patients with upper tract urothelial carcinoma. This study aimed to describe the impact of down-grading ipsilateral hydronephrosis by NAC for ureteral carcinoma. An observational study was conducted in 32 patients with cT1-3N0M0 ureteral carcinoma treated with NAC and radical nephroureterectomy. Hydronephrosis was classified into five grades based on computed tomography findings. We focused on the differences between the baseline and post-NAC status of ipsilateral hydronephrosis, radiographic tumor response, and blood markers. Down-grading, no change, and up-grading was observed in 10 (31%), 21 (66%), and 1 (3%) patients, respectively. In univariate analysis, locally advanced disease (cT3), severe hydronephrosis (grade 3/4) at baseline, no change/up-grading of hydronephrosis after NAC, and pathological lymphovascular involvement were identified as potential prognostic factors of progression-free and cancer-specific survival after radical nephroureterectomy. Locally advanced disease (cT3) at baseline and no change/up-grading of hydronephrosis by NAC were independently associated with poor progression-free survival. Notably, none of the patients with NAC-induced down-grading of hydronephrosis died of ureteral carcinoma during the follow-up. We reported the prognostic impact of down-grading of ipsilateral hydronephrosis, which could serve as a useful aid or clinical marker for decision-making.
topic ureteral neoplasms
hydronephrosis
neoadjuvant therapy
neoplasm recurrence
survival
disease progression
url https://www.mdpi.com/2075-4418/10/1/10
work_keys_str_mv AT makitomiyake downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma
AT nagaakimarugami downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma
AT yuyafujiwara downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma
AT kazumasakomura downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma
AT teruoinamoto downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma
AT haruhitoazuma downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma
AT hiroakimatsumoto downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma
AT hideyasumatsuyama downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma
AT kiyohidefujimoto downgradingofipsilateralhydronephrosisbyneoadjuvantchemotherapycorrelateswithfavorableoncologicaloutcomesinpatientsundergoingradicalnephroureterectomyforureteralcarcinoma
_version_ 1724931899840790528